Contineum Tx is a startup based in the United States.
Contineum Tx is a clinical-stage biopharmaceutical company developing small molecule therapies targeting neuroinflammation, immunology, and fibrotic diseases including idiopathic pulmonary fibrosis, chronic pain, and major depressive disorder.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.